Home > Healthcare > Pharmaceuticals > Finished Drug Form > Preterm Birth Prevention and Management Market

Preterm Birth Prevention and Management Market Trends

  • Report ID: GMI12732
  • Published Date: Dec 2024
  • Report Format: PDF

Preterm Birth Prevention and Management Market Trends

The market is experiencing several market trends that are shaping its growth and development. Factors such as increasing use of digital health solutions, growth in personalized medicine, and increased research and development in drug therapy, among other factors are boosting the industry growth.
 

  • Further, there is a growing trend toward personalized approaches to preterm birth prevention. Healthcare providers are increasingly using genetic screening, biomarkers, and individual risk profiles to tailor treatment plans for pregnant women. This trend allows for more targeted and effective prevention and management strategies, driving demand for personalized care solutions.
     
  • Moreover, the use of artificial intelligence in healthcare and machine learning in the prediction and management of preterm birth is on the rise. AI algorithms are being used to analyze patient data, such as medical history, lifestyle factors, and prenatal screenings, to predict the likelihood of preterm birth. These technologies are enhancing early risk detection and enabling healthcare providers to deliver more accurate, personalized care, thereby aforementioned factors are expected to drive the market.
Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The global preterm birth prevention and management industry was valued at USD 1.8 billion in 2024 and is projected to grow at a CAGR of 7.7% from 2025 to 2034, driven by increasing preterm birth rates and advancements in medical technology.

The progesterone therapy segment is expected to grow at a CAGR of 8%, reaching over USD 1.5 billion by 2034, as it significantly reduces the risk of preterm birth in high-risk women.

The U.S. market was valued at USD 671.6 million in 2024 and is anticipated to grow at a CAGR of 7.2% from 2025 to 2034, supported by the country’s relatively high preterm birth rate of approximately 10%.

Key players in the market include AbbVie, AMAG Pharmaceuticals, Ferring Pharmaceutical, Merck, Obseva, Pfizer, and Takeda Pharmaceutical.

Preterm Birth Prevention and Management Market Scope

Buy Now


Premium Report Details

  • Base Year: 2024
  • Companies covered: 7
  • Tables & Figures: 111
  • Countries covered: 19
  • Pages: 130
 Download Free Sample